The activation status of the guanosine triphosphate (GTP)-binding protein Ras is dictated by the relative intensities of two opposing reactions: the formation of active Ras-GTP complexes, promoted by guaninenucleotide exchange factors (GEFs), and their conversion to inactive Ras-GDP as a result of the deactivating action of GTPase-activating proteins (GAPs). The relevance of phosphoinositide 3-kinase (PI 3-kinase) to these processes is still unclear. We have investigated the regulation of Ras activation by PI 3-kinase in the myelomonocytic U937 cell line. These cells exhibited basal levels of Ras-GTP, which were suppressed by two PI 3-kinase inhibitors and a dominant-negative PI 3-kinase. In addition, PI 3-kinase inhibition aborted Ras activation by all stimuli tested, including foetal calf serum (FCS) and phorbol 12-myristate 13-acetate (TPA). Significantly, TPA does not activate PI 3-kinase in U937 cells, indicating that PI 3-kinase has a permissive rather than an intermediary role in Ras activation. Investigation of the mechanism of PI 3-kinase action revealed that inhibition of PI 3-kinase does not affect nucleotide exchange on Ras but abrogates Ras-GTP accumulation through an increase in GAP activity. These findings establish blockage of GAP action as the mechanism underlying a permissive function of PI 3-kinase in Ras activation. 
Results and discussion
To study Ras activation in myelomonocytic U937 cells we used the Ras-binding domain (RBD) pullout method [1] . As shown in Figure 1a , serum-starved U937 cells rapidly accumulate Ras-GTP upon stimulation with FCS. The two immunoreactive bands correspond to K-Ras and N-Ras (collectively referred to as Ras from here on; data not shown). Unstimulated cells reproducibly exhibited constitutive levels of Ras-GTP accounting for 3-5% of total Ras [2] [3] [4] . In the course of these experiments we obtained evidence of high nucleotide-exchange activity and GAP activity in U937 cells (see Supplementary material). To verify these indications, we investigated the nucleotideexchange and GAP reactions in vivo. We perfused streptolysin O (SLO)-permeabilised U937 cells with [α 32 P]GTP and followed the radioactivity associated with Ras in immunoprecipitations (IPs). Nucleotide uptake by Ras saturated after 2-3 minutes (Figure 1b ) and was too fast to be due to the intrinsic nucleotide-exchange rate of Ras [2] . The signal was chased by excess cold GTP and was fully dependent on the presence of SLO and the Ras-specific immunoprecipitating antibody Y13-259 ( Figure 1b , and data not shown). This result confirms the presence of active GEFs for Ras in resting U937 cells and is reminiscent of previous findings in unstimulated T cells [2] . To test Ras-GAP activity in vivo, we loaded permeabilised cells with recombinant, post-translationally unmodified [α 32 P]GTP-Ha-Ras. Whereas [α 32 P]GTP bound to wildtype Ha-Ras was rapidly converted to [α 32 P]GDP upon entrance into the cells, the GAP-insensitive, GTPase-deficient V12A38 Ha-Ras mutant [5] remained in the GTPbound form (Figure 1c ). These results demonstrate the existence of high cytosolic Ras-GAP activity in resting U937 cells. From these findings we conclude that Ras undergoes highly dynamic GDP-GTP cycling in resting U937 cells.
To test the possible participation of PI 3-kinases in the regulation of the Ras GDP-GTP cycle, we investigated the effect of various inhibitors on basal Ras-GTP accumulation. The two PI 3-kinase inhibitors wortmannin and LY294002 totally abrogated basal Ras-GTP formation (Figure 2a ). The tyrosine kinase (TK) inhibitor genistein also blocked Ras-GTP generation, whereas the widespectrum protein kinase inhibitor staurosporine reduced the signal by 70-80%. Inhibitors for MEK (PD98059) and PKC (bisindolylmaleimide IX), and the calcium ionophore ionomycin showed no effect. These results implicate PI 3-kinases and TKs in the control of the Ras GDP-GTP cycle in resting U937 cells. We next addressed the question of whether inhibition of basal Ras-GTP accumulation would preclude Ras activation by extracellular stimuli. Figure 2b shows that the two PI 3-kinase inhibitors blocked Ras-GTP accumulation induced by insulin, ATP, phorbol 12-myristate 13-acetate (TPA) and FCS. In contrast, genistein suppressed Ras activation by insulin, FCS and TPA, but did not prevent the ATP-dependent increase in Ras-GTP. Similarly, the two PKC inhibitors bisindolylmaleimide I and IX blocked Ras activation induced by TPA, but not that induced by ATP, FCS or insulin [3, 6, 7] . In conclusion, the two PI 3-kinase inhibitors were the only drugs that totally suppressed levels of basal Ras-GTP and Ras-GTP induced by all the stimuli tested. In this respect, the inhibition of TPA-induced Ras-GTP accumulation by wortmannin and LY294002 is of special significance, as it is well established that TPA does not activate PI 3-kinase in U937 and other myeloidderived cells [8, 9] . From these results we conclude that the role of PI 3-kinase in the control of Ras activation is permissive in nature.
Accumulation of cellular Ras-GTP depends on nucleotide exchange on Ras, catalysed by GEFs, and hydrolysis of Ras-bound GTP, which is mediated by GAP proteins. To determine which of these two reactions was regulated by PI 3-kinase, we analysed nucleotide exchange on Ras in inhibitor-treated cells. As shown in Figure 3a , neither of the two PI 3-kinase inhibitors reduced the initial rate of [α 32 P]nucleotide uptake by Ras. In fact, nucleotide uptake by Ras in control-and wortmannin-treated cells was virtually indistinguishable, indicating that PI 3-kinase is not necessary for nucleotide exchange on Ras in resting cells. Evaluation of Ras-bound [α 32 P]nucleotides by thin layer chromatography (TLC) confirmed that wortmannin treatment had abrogated Ras-GTP accumulation without affecting nucleotide uptake by Ras (Figure 3b ). Quantification of the GDP/GTP signals at steady state revealed 3-4% GTP/(GDP + GTP) in untreated and 0.3-0.7% GTP/(GDP + GTP) in wortmannin-treated cells. In marked contrast to the PI 3-kinase inhibitors, genistein and staurosporine blocked nucleotide exchange on Ras (Figure 3a ,b).
We recapitulated these findings by combining the permeabilisation protocol with the RBD pullout assay. We reasoned that the non-hydrolysable GTP analogue GTP-γ-S should drive Ras activation via uptake of GTP-γ-S by Ras independently of the presence of high GAP activity. As (Figure 3c ). In contrast, GTP-γ-S loading resulted in accumulation of active Ras in control and wortmannin-treated cells but not in cells treated with genistein. Although GTP-γ-S is likely to activate a number of cellular GTPases in this experiment, the result is nevertheless consistent with the notion that PI 3-kinase is not required for nucleotide exchange on Ras. We conclude from all these data that PI 3-kinase inhibits GAP action to allow formation of Ras-GTP.
The coincidence of effects elicited by wortmannin and LY294002, as observed throughout our experiments, is generally accepted as a solid criterion for the involvement of PI 3-kinase in biological processes. Moreover, doseresponse experiments with these inhibitors strongly implicated PI 3-kinase in the control of basal Ras-GTP generation (see Supplementary material). Nevertheless, to exclude an artefactual reaction of the PI 3-kinase inhibitors, we tested the effect of a dominant-negative PI 3-kinase on basal Ras-GTP formation. Addition of the kinase-dead p85α/K802R-p110α PI 3-kinase heterodimer [10] to permeabilised resting U937 cells resulted in a rapid drop of Ras-bound [α 32 P]GTP, whereas treatment with wild-type p85α/p110α was without effect (Figure 3d , left panel, and 3e). Interestingly, the adaptor subunit p85α on its own was less effective in suppressing Ras-GTP accumulation than the p85α/K802R-p110α complex (Figure 3d , right panel, and 3e), which suggested an important input at the level of the p110α subunit. Thus, the inhibitory effect of the kinase-dead PI 3-kinase on Ras-GTP accumulation consolidates the inhibitor data. Furthermore, the fact that wild-type PI 3-kinase did not increase Ras-GTP levels indicates that PI 3-kinase is not rate-limiting for Ras-GTP accumulation in resting U937 cells.
Taken together, our findings demonstrate bimodal regulation of Ras activity in resting U937 cells (Figure 4 ). In addition to the established stimulation of GEFs mediated by TKs, suppression of Ras-GAP action by PI 3-kinase is essential for accumulation of Ras-GTP. Our data provide strong evidence for a permissive role of PI 3-kinase in this process. This scenario provides an explanation for recent findings on a lack of stimulation of Ras or the ERK/Ras effector pathway by activated versions of PI 3-kinase [11] [12] [13] . These findings contradicted studies reporting a role of PI 3-kinase upstream of Ras [12, 14] , but can now be reconciled by assuming a permissive function of PI 3-kinase in Ras activation. In particular, the non-rate-limiting nature of this PI 3-kinase function can explain the ineffectiveness of constitutively active PI 3-kinases in promoting Ras/ERK activation [11, 12] . Furthermore, GAP inhibition by PI 3-kinase may underlie recent findings on the sensitivity to wortmannin or LY294002 of Ras activation by low doses of extracellular agonists [12] . We have not been able to overcome the PI 3-kinase inhibitor block with high doses of agonists (Figure 2b , and data not shown),
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Figure 3
The role of PI 3-kinase and TKs in the regulation of the Ras GDP-GTP cycle in resting U937 cells. in contrast to results in COS cells [12] . This failure may be related to the particularly high level of GAP activity in U937 cells. If this explanation turns out to be valid, the impact of GAP inhibition by PI 3-kinase on Ras activation may vary among cell types, depending on different cellspecific properties that affect the magnitude and agonist sensitivity of Ras-GTP accumulation.
The increase in GAP activity induced by PI 3-kinase inhibitors indicates that resting levels of the lipids produced in the plasma membrane by PI 3-kinase inhibit the action of GAP proteins on Ras. We found that wortmannin pretreatment of U937 cells did not alter GAP activity as assayed from cell lysates (data not shown). This suggests that membrane integrity is important for PI3-kinase-mediated inhibition of GAPs. Considering that Ras can activate PI 3-kinase through a direct interaction with the p110 catalytic subunit [15] , our data suggest the following scenario. Active Ras could activate PI 3-kinase to induce spatially restricted generation of 3-phosphoinositides. This would promote local downregulation of relevant GAP species and thus allow basal Ras activation.
Supplementary material
Supplementary material including the results of PI 3-kinase inhibitor dose-response experiments, and RBD pullout assays confirming high GEF and GAP activity in resting U937 cells, as well as detailed methodology is available at http://current-biology.com/supmat/supmatin.htm. 
